{"url_path":"/sec/ipsc/8-k/2026-05-13/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-059824-index.html","accession_number":"0001104659-26-059824","cik":"0001850119","ticker":"IPSC","issuer_name":"Century Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1850119/0001104659-26-059824-index.html","primary_entity_key":"0001850119","primary_entity_name":"Century Therapeutics, Inc."},"word_count":87,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits**\n\n \n\n**(d) Exhibits**\n\n \n\n**Exhibit\nNo.**\n \n**Document**\n\n[99.1](tm2614312d1_ex99-1.htm)\n \n[Press Release of Century\nTherapeutics, Inc., dated May 13, 2026](tm2614312d1_ex99-1.htm)\n\n104\n \nCover Page Interactive\nData File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**CENTURY THERAPEUTICS, INC.**\n\n \n \n \n\n \nBy:\n/s/ Brent Pfeiffenberger, Pharm.D.\n\n \nName:\nBrent Pfeiffenberger, Pharm.D.\n\n \nTitle:\nPresident and Chief Executive Officer\n\n \n\nDate: May 13, 2026"}